Walron Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.40 Cr
as on 24-10-2024
- Paid Up Capital ₹ 1.38 Cr
as on 24-10-2024
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.29 Cr
as on 24-10-2024
- Revenue 36.76%
(FY 2023)
- Profit 36.14%
(FY 2023)
- Ebitda 26.87%
(FY 2023)
- Net Worth 35.31%
(FY 2023)
- Total Assets 23.35%
(FY 2023)
About Walron Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.40 Cr and a paid-up capital of Rs 1.38 Cr.
The company currently has active open charges totaling ₹1.29 Cr.
Madan Sharma, Devi Singh, and Dungar Sharma serve as directors at the Company.
- CIN/LLPIN
U24232RJ2015PTC047350
- Company No.
047350
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Apr 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Walron Healthcare Private Limited offer?
Walron Healthcare Private Limited offers a wide range of products and services, including Projector, Epson Projector.
Who are the key members and board of directors at Walron Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madan Sharma  | Director | 10-Apr-2015 | Current |
| Devi Singh | Director | 23-Mar-2017 | Current |
| Dungar Sharma | Director | 10-Apr-2015 | Current |
Financial Performance of Walron Healthcare.
Walron Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 36.76% increase. The company also saw a substantial improvement in profitability, with a 36.14% increase in profit. The company's net worth Soared by an impressive increase of 35.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Walron Healthcare?
In 2023, Walron Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 11 Jan 2024 | ₹1.00 Cr | Open |
Hdfc Bank Limited Creation Date: 21 Nov 2023 | ₹1.42 M | Open |
Axis Bank Limited Creation Date: 21 Oct 2020 | ₹1.44 M | Open |
How Many Employees Work at Walron Healthcare?
Walron Healthcare has a workforce of 92 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Walron Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Walron Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
